Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

Blood (2015) 125 (25): 3835–3850.

https://doi.org/10.1182/blood-2015-03-631853

Published: 2015

Includes: Supplemental data

Journal Articles

Detection of NFKB2 3’end Loos By Quantitative PCR (QPCR) or Detection of NFKB2 Rearrangements Correlate with Bortezomib Response in Multiple Myeloma

Sampath Ramachandiran, PhD, Jean L. Koff, MD, Laurent Garderet, MD, Debra Saxe, PhD, Souhila Ikhlef, MD, Nyaya Kelkar, PhD, Lee Kaplan, Jean El-Cheikh, Jeffrey M. Switchenko, PhD, Susan Sunay, Hanna J. Khoury, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Lawrence H Boise, PhD, Jeanne Kowalski, PhD, Leon Bernal-Mizrachi, MD

Blood (2014) 124 (21): 2138.

https://doi.org/10.1182/blood.V124.21.2138.2138

Published: 2014

Journal Articles

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

Taro Hitosugi, PhD, Lu Zhou, PhD, Jun Fan, PhD, Martha Arellano, MD, Hanna J. Khoury, MD, Benjamin H. Lee, MD, PhD, Titus Boggon, PhD, Sumin Kang, PhD, Chuan He, Jing Chen, PhD

Blood (2012) 120 (21): 860.

https://doi.org/10.1182/blood.V120.21.860.860

Published: 2012

Journal Articles

A First-in-Disease Trial of in Vivo Costimulation Blockade for Acute GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD

Divya Tiwari, MD, John Horan, Amelia Langston, MD, Muna Qayed, M.D., M.Sc., Jennifer Carr, Heather Renfroe, Couture Cynthia, Hanna J. Khoury, MD, Robertson Jennifer, R. Donald Harvey, PharmD, Aneesh Mehta, Edmund K. Waller, MD, PhD, Leslie S. Kean, MD, PhD

Blood (2012) 120 (21): 741.

https://doi.org/10.1182/blood.V120.21.741.741

Published: 2012

Journal Articles

Truncation of NF-KB2 Is Associated with Poor Response to Bortezomib Treatment in Multiple Myeloma

Sampath Ramachandiran, PhD, Xiangxue Guo, PhD, Laurent Garderet, MD, Souhila Ikhlef, MD, Jean El-cheikh, MD, Michael R Weil, PhD, Andrew N Young, M. D., Ph.D., Mahir Bagirov, Sagar Lonial, MD, Zhengjia Chen, PhD, Jeanne Kowalsky, PhD, Yuhong Du, Ph.D, Hanna J. Khoury, MD, Susan Sunay, Jonathan L. Kaufman, MD, Lawrence H. Boise, PhD, Michael Rossi, PhD, Leon Bernal-Mizrachi, MD

Blood (2011) 118 (21): 2891.

https://doi.org/10.1182/blood.V118.21.2891.2891

Published: 2011

Journal Articles

p90RSK2 is essential for FLT3-ITD– but dispensable for BCR-ABL–induced myeloid leukemia

Shannon Elf, Dean Blevins, Lingtao Jin, Tae-Wook Chung, Ifor R. Williams, Benjamin H. Lee, Jian-Xin Lin, Warren J. Leonard, Jack Taunton, Hanna J. Khoury, Sumin Kang

Blood (2011) 117 (25): 6885–6894.

https://doi.org/10.1182/blood-2010-10-315721

Published: 2011

Includes: Supplemental data

Journal Articles

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

Vikas Gupta, Martin S. Tallman, Wensheng He, Brent R. Logan, Edward Copelan, Robert Peter Gale, Hanna J. Khoury, Thomas Klumpp, John Koreth, Hillard M. Lazarus, David I. Marks, Rodrigo Martino, David A. Rizzieri, Jacob M. Rowe, Mitchell Sabloff, Edmund K. Waller, John F. DiPersio, Donald W. Bunjes, Daniel J. Weisdorf

Blood (2010) 116 (11): 1839–1848.

https://doi.org/10.1182/blood-2010-04-278317

Published: 2010

Journal Articles

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

John Horan, MD, MPH, Brent R. Logan, PhD, Manza-A. Agovi, MPH, Hillard M Lazarus, MD, Andrea Bacigalupo, MD, Karen Ballen, Rodrigo Martino, Mark B. Juckett, MD, Hanna J. Khoury, MD, Christopher Bredeson, MD, Vikas Gupta, Franklin O. Smith, MD, Gregory Hale, Matthew Carabasi, MD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS, Marcelo C. Pasquini, MD

Blood (2009) 114 (22): 649.

https://doi.org/10.1182/blood.V114.22.649.649

Published: 2009

Journal Articles

Patulin, a Mycotoxin, Has Potent Cytotoxic Activity on Actue Lymphoblastic Leukemia and Induce Apoptosis through Intrinsic and Extrinsic Pathways.

Fengrong Wang, MD, Ebeneier David, PhD, Sagar Lonial, MD, Martha Arellano, MD, Hanna J. Khoury, MD, Amelia Langston, MD, Mary Jo Lechowicz, MD, Ned Waller, MD PhD

Blood (2007) 110 (11): 4334.

https://doi.org/10.1182/blood.V110.11.4334.4334

Published: 2007

Journal Articles

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation

Hanna J. Khoury, Fausto R. Loberiza, Jr, Olle Ringdén, A. John Barrett, Brian J. Bolwell, Jean-Yves Cahn, Richard E. Champlin, Robert Peter Gale, Gregory A. Hale, Alvaro Urbano-Ispizua, Rodrigo Martino, Philip L. McCarthy, Pierre Tiberghien, Leo F. Verdonck, Mary M. Horowitz

Blood (2006) 107 (4): 1712–1716.

https://doi.org/10.1182/blood-2005-07-2661

Published: 2006

Journal Articles

Patient Characteristics in CD 20 + and CD 20 − Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis.

Sara P. Gladney, MD, Leonard T. Heffner, MD, Amelia Langston, MD, Jeannine Holden, MD, Carol Phillips, MD, Elliott Winton, MD, Christopher R. Flowers, MD, Mary Jo Lechowicz, MD, Sagar Lonial, MD, Edmund Waller, MD, PhD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 4523.

https://doi.org/10.1182/blood.V106.11.4523.4523

Published: 2005

Journal Articles

Prognostic Significance of Early Peripheral Blood Blasts Clearance Following Induction Chemotherapy for Adult Acute Myeloid Leukemia.

Suchita Pakkala, MD, Elliott Winton, MD, Amelia Langston, MD, Leonard T. Heffner, MD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 4631.

https://doi.org/10.1182/blood.V106.11.4631.4631

Published: 2005

Journal Articles

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Amelia A. Langston, MD, Leonard T. Heffner, MD, Donald Hutcherson, RPh, Jessica Neely, MS, Christopher Flowers, MD, MS, Edmund K. Waller, MD, PhD, Sagar Lonial, MD, Hanna J. Khoury, MD, Elliot Winton, MD

Blood (2005) 106 (11): 4634.

https://doi.org/10.1182/blood.V106.11.4634.4634

Published: 2005

Journal Articles

A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.

William S. Jonas, MD, Matthew Hogan, MD, Allan F. Platt, PA, Melanie Jacob, MD, JoAnn A. Beasley, RN, Philip Lamson, Sheila Palmer, PA, Hanna J. Khoury, MD, James R. Eckman, MD

Blood (2005) 106 (11): 1339.

https://doi.org/10.1182/blood.V106.11.1339.1339

Published: 2005

Journal Articles

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

Tom Fong, MD, Kim Trinkaus, PhD, Douglas R. Adkins, MD, Ravi Vij, MD, Steven Devine, MD, Michael Tomasson, MD, Lawrence T. Goodnough, MD, Timothy Graubert, MD, Shalini Shenoy, MD, John F. DiPersio, MD, PhD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 1800.

https://doi.org/10.1182/blood.V106.11.1800.1800

Published: 2005

Journal Articles

A Clinical Database Supports Better Patient Care, and Clinical Research in a Sickle Cell Center at a Large County Hospital.

William S. Jonas, MD, Melanie Cooper, MD, Allan F. Platt, PA, JoAnn Beasley, RN, Sheila Palmer, PA, Hanna J. Khoury, MD, James R. Eckman, MD

Blood (2005) 106 (11): 5579.

https://doi.org/10.1182/blood.V106.11.5579.5579

Published: 2005

Journal Articles

Vancomycin Resistant Enterococcus (VRE) Bloodstream Infections (BSI) in Patients with Hematological Malignancies: Is the Sick Getting Sicker?.

Erik R. Dubberke, MD, James Holland, PharmD, Peter Georgantopolis, MPH, Kristan Augustin, PharmD, John F. Dipersio, MD, PhD, Linda Mundy, MD, Hanna J. Khoury, MD

Blood (2005) 106 (11): 5373.

https://doi.org/10.1182/blood.V106.11.5373.5373

Published: 2005

Journal Articles

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Geoffrey L. Uy, M.D., Nicholas M. Fisher, B.S., Steven M. Devine, M.D., Hanna J. Khoury, M.D, Douglas R. Adkins, M.D., Michael H. Tomasson, M.D, Timothy A. Graubert, M.D., John F. DiPersio, M.D., Ph.D., Ravi Vij, M.D.

Blood (2004) 104 (11): 541.

https://doi.org/10.1182/blood.V104.11.541.541

Published: 2004

Journal Articles

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation

Ravi Vij, John F. DiPersio, Partha Venkatraman, Kathryn Trinkaus, Lawrence T. Goodnough, Randy A. Brown, Hanna J. Khoury, Steven M. Devine, Aarti Oza, Shalini Shenoy, William Blum, Douglas Adkins

Blood (2003) 101 (5): 2067–2069.

https://doi.org/10.1182/blood-2002-07-2110

Published: 2003

NARROW

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

Detection of NFKB2 3’end Loos By Quantitative PCR (QPCR) or Detection of NFKB2 Rearrangements Correlate with Bortezomib Response in Multiple Myeloma

Phosphoglycerate Mutase 1 Promotes Leukemia Metabolism by Coordinating Glycolysis and Biosynthesis, and Represnts a Therapuetic Target in Leukemia Treatment

A First-in-Disease Trial of in Vivo Costimulation Blockade for Acute GvHD Prevention: The Addition of Abatacept to Standard GvHD Prophylaxis Controls Early CD4+ T Cell Proliferation and Is Associated with Low Rates of Severe Acute GvHD

Truncation of NF-KB2 Is Associated with Poor Response to Bortezomib Treatment in Multiple Myeloma

p90RSK2 is essential for FLT3-ITD– but dispensable for BCR-ABL–induced myeloid leukemia

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

Patulin, a Mycotoxin, Has Potent Cytotoxic Activity on Actue Lymphoblastic Leukemia and Induce Apoptosis through Intrinsic and Extrinsic Pathways.

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation

Patient Characteristics in CD 20 + and CD 20 − Adult Acute Lymphoblastic Leukemia (ALL): A Single Institution Analysis.

Prognostic Significance of Early Peripheral Blood Blasts Clearance Following Induction Chemotherapy for Adult Acute Myeloid Leukemia.

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.

A Randomized, Double Blind Trial, of Hydroxychloroquine for the Prevention of Graft-Versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.

A Clinical Database Supports Better Patient Care, and Clinical Research in a Sickle Cell Center at a Large County Hospital.

Vancomycin Resistant Enterococcus (VRE) Bloodstream Infections (BSI) in Patients with Hematological Malignancies: Is the Sick Getting Sicker?.

Bortezomib Given in Sequence with Anthracycline and Thalidomide-Containing Regimens Does Not Adversely Affect Stem Cell Mobilization and Engraftment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.

Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only